<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04398381</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0289</org_study_id>
    <nct_id>NCT04398381</nct_id>
  </id_info>
  <brief_title>Prognosis of SRD Patients in the ICU</brief_title>
  <acronym>ProSyDICU</acronym>
  <official_title>One-year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: a Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sorbonne University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Lariboisière Fernand Widal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision
      of rheumatic and critical care in recent years. Recent comprehensive data regarding
      in-hospital mortality and most importantly long-term outcome are scarce. The aim of this
      study is to assess short and long-term outcome of patients with SRD admitted to the ICU in a
      retrospective cohort study (2006 - 2016).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate in the ICU associated risk factors</measure>
    <time_frame>1 day</time_frame>
    <description>Mortality rate in the ICU associated risk factors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality rate in the hospital and one-year after ICU admission and associated risk factors</measure>
    <time_frame>1 day</time_frame>
    <description>Mortality rate in the hospital and one-year after ICU admission and associated risk factors</description>
  </secondary_outcome>
  <enrollment type="Actual">525</enrollment>
  <condition>Systemic Rheumatic Diseases</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Corticosteroids</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive SRD patients admitted to ICUs during the study period
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  All consecutive SRD patients admitted to ICUs during the study period

          -  at least one urine sample

        Exclusion criteria:

          -  Age &lt; 18 years

          -  Persons under protection

          -  Paritcipation rejections

          -  Admition to the ICU after scheduled surgery or trauma or suicide attempt unrelated to
             neurological involvement of SRD

          -  Cancer treated with chemotherapy within a month before ICU admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romaric Larcher, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>UH Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>outcomes</keyword>
  <keyword>prognostic factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

